Tyler Flores

A top advisory firm’s new security milestone reveals a critical truth: protecting pharma and biotech IP now depends on the digital defenses of all partners.

A new SPAC targets AI infrastructure, the bedrock of modern medicine. But with controversial leadership, is this a savvy play or a high-risk gamble?

Digital commerce firm Amaze is opening a physical studio, a high-stakes bet that hardware and services are the key to owning the creator economy.

Despite an FDA-approved product, Clearside Biomedical files for Chapter 11, putting its revolutionary eye-drug tech and a Phase 3 asset up for grabs.

After terminating a mega-merger with Performance Food Group, US Foods charts its own course with a massive share buyback, signaling confidence to investors.

A new rating from KBRA highlights a growing trend in the mortgage-backed securities market: a surge in non-conforming loans. Is this a sign of increased risk or a healthy expansion of credit access?

Strong US jobs data defied recession fears, while Fidelity’s potential Solana fund launch underscores growing institutional interest in digital assets. Is this the tipping point for crypto adoption?

Colombia's insurance sector is experiencing divergent trends. While life insurance premiums climb to new heights, rising financial leverage in the non-life segment is raising eyebrows amongst analysts and regulators.

New forecasts predict a $385B US ABS market in 2026, but a ‘K-shaped’ economy and policy shifts create headwinds for credit card and solar-backed securities. Investors must adapt to a landscape of diverging fortunes.

New analysis reveals growing risks in auto, retail, and higher education, fueled by automation, shifting consumer habits, and a mounting student debt crisis. Investors and policymakers take note.

Despite economic headwinds and a delayed jobs report, US markets show pockets of resilience fueled by strong corporate earnings. Analysts weigh the impact of the government shutdown and a shifting Fed outlook.

Palliser Capital is challenging Japan Post Holdings to realize its full potential, highlighting undervalued assets and advocating for strategic changes in the face of demographic shifts and evolving market dynamics.

New York Stock Exchange hosted bell-ringing events for AI Infrastructure Acquisition & Optimum alongside market gains and cautious Fed signals. NVIDIA’s earnings remain a key focus.

New York Stock Exchange hosted its International Day, signaling a surge in overseas companies seeking US capital. Experts point to a competitive advantage for NYSE as global markets evolve.

Galloway Capital Partners takes a 3.15% stake in PodcastOne, urging a sale or merger. Can the podcasting platform unlock value amid industry consolidation and a shifting audio landscape?

Global insights leader Ipsos has been ranked #1 in innovation for the third consecutive year, driven by investments in AI and advanced analytics. The firm’s success reflects a broader industry shift towards tech-driven solutions.

Partnership aims to democratize access to generative AI by combining specialized hardware acceleration with a high-performance vector database, addressing a key barrier to wider adoption.

Driven by health & wellness trends, India's amino acid market is set for substantial expansion. However, reliance on imports and limited domestic production capacity pose significant challenges for sustained growth.

New research forecasts significant growth in India's atorvastatin market, driven by healthcare demands & economic factors, while highlighting vulnerabilities in the pharmaceutical supply chain and a crucial factual error regarding the drug's role in malaria treatment.

A new report forecasts strong growth in the US hormone therapy market, driven by an aging population, but persistent supply chain disruptions and inconsistent insurance coverage threaten access for patients.